NPHS2 and focal segmental glomerulosclerosis: Additionally, podocin and uPAR have been identified as effective biomarkers in distinguishing FSGS from MCD in pediatric renal biopsies, with podocin showing a sensitivity of 73.3% and specificity of 86.7% [83].